(3R, 4R)-4-'3-(S)-HYDROXY-3-(6-MEHTOX YQUINOLIN-4-YL) PROPYLI (-1-'2-(2-THIENYLTHIO) ETHYL )IPIPERIDINE-3-CARBOXYLIC ACID CRYSTALLINE FORM

Details for Australian Patent Application No. 2003299359 (hide)

Owner AVENTIS PHARMA S.A

Inventors BILLOT, Pascal; BOURGET, Jacques; JANOCHA, Bernd; LAFONT, Sylvaine; NEVES, Carole; PERRIN, Marc Antoine

Pub. Number AU-A-2003299359

PCT Number PCT/FR2003/0038

PCT Pub. Number WO2004/060886

Priority 02/16418 20.12.02 FR

Filing date 19 December 2003

Wipo publication date 29 July 2004

International Classifications

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 02/16418 20.12.02 FR

2 September 2004 Application Open to Public Inspection

  Published as AU-A-2003299359

15 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003299360-Compounds for oral dosage of active substances requiring a taste masking

2003299358-All-optical converter